No. |
Project Title |
Agency* |
Project Dates |
Amount |
| 1. |
Regulation of P. aeruginosa β -lactamase genes
(Role: PI)
|
NIH-MBRS SCORE |
04/05 – 03/08 |
$415,205 |
| 2. |
Ginseng as an antibacterial agent against Pseudomonas aeruginosa
(Role: PI; Co-PI: M. Quirke, Chemistry)
|
NIH-R15 AREA |
10/04 – 10/07 |
$150,000 |
| 3. |
Development of a mold remediation process using hydrogen peroxide catalyzed by Fe(II) Ions
(Role: Co-PI; PI: G. Tachiev, FIU HCET)
|
Environ. Protection Agency |
07/04 – 07/05 |
$90,150
(Total: $261,500) |
| 4. |
Microbial community organization and development of a pathogenic microbial corsortium
(Role: Co-Investigator; PI: L. Richardson)
|
NIH-MBRS SCORE |
02/04-01/08 |
$845,678 |
| 5. |
Training in alternative tropical botanical medicine
(Role: CoPI )
|
NIH-NCCAM |
01/02-12/06 |
$1,146,485 |
| 6. |
Title: Effect of ginseng on the expression of virulence factors in Pseudomonas aeruginosa
(Role: Mentor)
|
NIH- MBRS MARC |
01/02-05/05 |
|
| 7. |
Effect of ginseng on the expression of virulence factors in Pseudomonas aeruginosa
(Role: Mentor; PI: C. Bigger )
|
NIH-MBRS MARC |
04/01- 12/05 |
|
| 8. |
Regulation of beta-lactamase genes of Pseudomonas aeruginosa
(Role: PI)
|
NIH-MBRS SCORE S06 GM08205 |
04/01-03/04 |
$482,402 |
| 9. |
Ginseng as a possible therapeutic agent
(Role: PI)
|
Cystic Fibrosis Foundation |
04/01-03/02 |
$43,200 |
| 10. |
Mucoid conversion of P. aeruginosa associated with chronic pulmonary infection in patients
(Role: Mentor)
|
NIH- MBRS RISE: R25 GM61347 |
04/00-05/04 |
|
| 11. |
Investigation for the effect of Chinese herb ginseng, provided by Dansk Droge A/S, on Pseudomonas aeruginosa associated with CF patients
(Role: CoPI)
|
Dansk Droge A/S |
08/00-07/01 |
$37,500 |
| 12. |
Mucoid conversion of P. aeruginosa associated with chronic pulmonary infection in patients
(Role: Mentor; PI: C. Bigger)
|
NIH- MBRS RISE: R25 GM61347 |
04/99-12/05 |
|
| 13. |
Molecularbiological and immunobiological strategies for prevention and treatment of P.aeruginosa from chronic lung infection in cystic fibrosis
(Role: CoPI)
|
Danish Research Council |
01/98-12/01 |
$321,000 |